Mitochondrial-regulated Tregs: potential therapeutic targets for autoimmune diseases of the central nervous system

被引:1
|
作者
Han, Aoya [1 ]
Peng, Tingting [1 ]
Xie, Yinyin [1 ]
Zhang, Wanwan [1 ]
Sun, Wenlin [1 ]
Xie, Yi [1 ]
Ma, Yunqing [1 ]
Wang, Cui [2 ]
Xie, Nanchang [1 ]
机构
[1] Zhengzhou Univ, Dept Neurol, Affiliated Hosp 1, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Dept Clin Lab, Affiliated Hosp 1, Zhengzhou, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
基金
中国国家自然科学基金;
关键词
mitochondria; regulatory T cell; Foxp3; self-tolerance; central nervous system; autoimmune diseases; T-CELL DIFFERENTIATION; FOXP3; METABOLISM; HYPOXIA; DYSFUNCTION; HIF-1-ALPHA; ACTIVATION; INHIBITION; DEHYDROGENASE; INSTABILITY;
D O I
10.3389/fimmu.2023.1301074
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Regulatory T cells (Tregs) can eliminate autoreactive lymphocytes, induce self-tolerance, and suppress the inflammatory response. Mitochondria, as the energy factories of cells, are essential for regulating the survival, differentiation, and function of Tregs. Studies have shown that patients with autoimmune diseases of the central nervous system, such as multiple sclerosis, neuromyelitis optica spectrum disorder, and autoimmune encephalitis, have aberrant Tregs and mitochondrial damage. However, the role of mitochondrial-regulated Tregs in autoimmune diseases of the central nervous system remains inconclusive. Therefore, this study reviews the mitochondrial regulation of Tregs in autoimmune diseases of the central nervous system and investigates the possible mitochondrial therapeutic targets.
引用
收藏
页数:9
相关论文
共 50 条
  • [11] Therapeutic implications of Apolipoprotein E genotype in autoimmune inflammatory diseases of the central nervous system
    Schrewe, Lisa
    Gold, Ralf
    Chan, Andrew
    JOURNAL OF NEUROIMMUNOLOGY, 2014, 275 (1-2) : 226 - 226
  • [12] Emerging functions and therapeutic targets of IL-38 in central nervous system diseases
    Gao, Yuan
    Cai, Luwei
    Wu, Yulu
    Jiang, Min
    Zhang, Yidan
    Ren, Wenjing
    Song, Yirui
    Li, Lili
    Lei, Ziguang
    Wu, Youzhuang
    Zhu, Luwen
    Li, Jing
    Li, Dongya
    Li, Guohong
    Luo, Chengliang
    Tao, Luyang
    CNS NEUROSCIENCE & THERAPEUTICS, 2024, 30 (02)
  • [13] Mitochondrial uncoupling as a potential therapeutic target in acute central nervous system injury
    Maragos, WF
    Korde, AS
    JOURNAL OF NEUROCHEMISTRY, 2004, 91 (02) : 257 - 262
  • [14] Central nervous system involvement in autoimmune rheumatic diseases
    Cikes, Nada
    Bosnic, Dubravka
    Sentic, Mirna
    Mayer, Miroslav
    Baresic, Marko
    Cerovec, Mislav
    Anic, Branimir
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (05) : 716 - 716
  • [15] In vivo imaging in autoimmune diseases in the central nervous system
    Kawakami, Naoto
    ALLERGOLOGY INTERNATIONAL, 2016, 65 (03) : 235 - 242
  • [16] Childhood autoimmune neurologic diseases of the central nervous system
    Jones, CT
    NEUROLOGIC CLINICS, 2003, 21 (04) : 745 - +
  • [17] Tryptophan Metabolism in Central Nervous System Diseases: Pathophysiology and Potential Therapeutic Strategies
    Huang, Yinrou
    Zhao, Mengke
    Chen, Xuemei
    Zhang, Ruoyu
    Le, Anh
    Hong, Michael
    Zhang, Yufei
    Jia, Lin
    Zang, Weidong
    Jiang, Chao
    Wang, Junmin
    Fan, Xiaochong
    Wang, Jian
    AGING AND DISEASE, 2023, 14 (03): : 858 - 878
  • [18] The Potential Therapeutic Effects of Artesunate on Stroke and Other Central Nervous System Diseases
    Zuo, Shilun
    Li, Qiang
    Liu, Xin
    Feng, Hua
    Chen, Yujie
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [19] Isorhynchophylline: A plant alkaloid with therapeutic potential for cardiovascular and central nervous system diseases
    Zhou, Ji-Yin
    Zhou, Shi-Wen
    FITOTERAPIA, 2012, 83 (04) : 617 - 626
  • [20] Circular RNAs: Potential biomarkers and therapeutic targets for autoimmune diseases
    Zhao, Ren-Jie
    Zhang, Wan-Ying
    Fan, Xing-Xing
    HELIYON, 2024, 10 (01)